期刊文献+

去白细胞输血治疗急性白血病的效果分析 被引量:1

Analysis of the Effect of Leukocyte-removed Blood Transfusion on Acute Leukemia
下载PDF
导出
摘要 目的探讨去白血病输血治疗急性白血病的效果。方法随机抽样法选取近一年浙江省海宁市人民医院62例急性白血病患者。随机数字表法分组:对照组(31例)给予常规输血治疗,研究组(31例)给予去白细胞输血治疗。比较两组疗效。结果治疗后,研究组有效率(93.55%)高于对照组(70.97%)(P<0.05);研究组CD4+、CD4+/CD8+高于对照组,CD8+低于对照组(P<0.05);研究组Th1、Th1/Th2高于对照组,Th2低于对照组(P<0.05)。结论急性白血病采用去白细胞输血治疗可增强疗效,改善细胞免疫功能。 Objective To investigate the effect of treating acute leukemia by blood transfusion.Methods 62 patients with acute leukemia in Haining People’s Hospital were selected by random sampling.Randomized number table method:the control group(31 cases)received routine blood transfusion,and the study group(31 cases)received leucocyte-free blood transfusion.The efficacy of the two groups was compared.Results After treatment,the effective rate of the study group(93.55%)was higher than that of the control group(70.97%)(P<0.05).CD4+and CD4+/CD8+in the study group were higher than those in the control group,and CD8+were lower than those in the control group(P<0.05).Th1 and Th1/Th2 of the study group were higher than those of the control group,while Th2 was lower than that of the control group(P<0.05).Conclusion The treatment of acute leukemia by blood transfusion can enhance the curative effect and improve the cellular immune function.
作者 冯晓林 周秀杰 朱晓维 毛莎莎 FENG Xiaolin;ZHOU Xiujie;ZHU Xiaowei;MAO Shasha(Haining People's Hospital,Haining 314400,China)
出处 《中国全科医学》 CAS 北大核心 2021年第S01期129-130,共2页 Chinese General Practice
关键词 急性白血病 去白细胞输血 效果 细胞免疫功能 Acute leukemia Leucocyte transfusion Effect Cellular immune function
  • 相关文献

参考文献6

二级参考文献41

  • 1王鸿雁,王芹.临床输血不良反应及护理要点[J].吉林医药学院学报,2012,33(3):156-157. 被引量:5
  • 2于洋,刘景汉,欧阳锡林,吕留彩,韩玮,李锡金.去白细胞输血在小儿心脏直视手术中的应用研究[J].中国输血杂志,2004,17(3):155-157. 被引量:14
  • 3李海云,卢叶香.过量氟对肾组织细胞周期影响的探讨[J].医学动物防制,2005,21(10):708-709. 被引量:8
  • 4聂慧芳,周克礼,张鹏,薛双林,梁世艳.血站型去白细胞血液制品的应用[J].中国输血杂志,2006,19(2):130-132. 被引量:21
  • 5Delaney M,Mayock D,Knezevic A,et al.Postnatal cytomegalovirus infection:a pilot comparative effectiveness study of transfusion safety using leukoreduced-only transfusion strategy. Transfusion . 2016
  • 6CAMPO E, SWERDLOW S H, HARRIS N L, et al. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications [J]. Blood, 2011, 117 (19) :5019 -5032.
  • 7ARBER D A, ORAZI A, HASSERJ1AN R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia [J]. Blood, 2016, 127 (20) : 2391 -2405.
  • 8GROSCHEL S, SANDERS M A, HOOGENBOEZEM R, et al. A single oncogenic enhancer rearrangement causes concomitant EVIl and GATA2 deregulation in leukemia [J]. Cell, 2014, 157 (2) : 369 -381.
  • 9KONOPLEV S, YIN C C, KORNBLAU S M, et al. Molecular characterization of de novo philadelphia chromosome - positive acute myeloid leukemia [ J]. Leuk Lymphoma, 2013, 54 ( 1 ) : 138 - 144.
  • 10NACHEVA E P, GRACE C D, BRAZMA D, et al. Does BCR/ ABL1 positive acute myeloid leukaemia exist? [ J ]. Br J Haematol, 2013, 161 (4): 541-550.

共引文献101

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部